This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Melker, H. E.
Right arrow Articles by Schellekens, J. F. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Melker, H. E.
Right arrow Articles by Schellekens, J. F. P.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, February 2000, p. 800-806, Vol. 38, No. 2
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Specificity and Sensitivity of High Levels of Immunoglobulin G Antibodies against Pertussis Toxin in a Single Serum Sample for Diagnosis of Infection with Bordetella pertussis

H. E. de Melker,1 F. G. A. Versteegh,2 M. A. E. Conyn-van Spaendonck,1 L. H. Elvers,3 G. A. M. Berbers,4 A. van der Zee,5 and J. F. P. Schellekens3,*

Department of Infectious Diseases Epidemiology,1 Diagnostic Laboratory for Infectious Diseases and Perinatal Screening,3 and Laboratory for Clinical Vaccine Research,4 National Institute of Public Health and the Environment, Bilthoven, Department of Pediatrics, `Groene Hart' Hospital, Gouda,2 and Laboratory of Medical Microbiology, St. Elisabeth Hospital, Tilburg,5 The Netherlands

Received 16 July 1999/Returned for modification 28 September 1999/Accepted 1 November 1999

Laboratory confirmation of pertussis by culture, PCR, or detection of antibody increase in paired sera is hampered by low sensitivity in the later stages of the disease. Therefore, we investigated whether, and at which level, concentrations of immunoglobulin G (IgG) antibodies against pertussis toxin (PT), IgG-PT, in a single serum sample are indicative of active or recent pertussis. IgG-PT, measured by enzyme-linked immunosorbent assay in units per milliliter, was analyzed in 7,756 sera collected in a population-based study in The Netherlands, in the sera of 3,491 patients with at least a fourfold increase of IgG-PT, in paired sera of 89 patients with positive cultures and/or PCR results, and in the sera of 57 patients with clinically documented pertussis with a median follow-up of 1.4 years. We conclude that, independently of age, IgG-PT levels of at least 100 U/ml are diagnostic of recent or active infection with Bordetella pertussis. Such levels are present in less than 1% of the population and are reached in most pertussis patients within 4 weeks after disease onset and persist only temporarily.

* Corresponding author. Mailing address: Diagnostic Laboratory for Infectious Diseases and Perinatal Screening, National Institute of Public Health and the Environment, P.O. Box 1, 3720 BA Bilthoven, The Netherlands. Phone: 31-30-274-2190. Fax: 31-30-274-4418. E-mail: j.schellekens{at}rivm.nl.

Journal of Clinical Microbiology, February 2000, p. 800-806, Vol. 38, No. 2
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Harnden, A. (2009). Whooping cough. BMJ 338: b1772-b1772 [Full Text]  
  • Xing, D., Wirsing von Konig, C. H., Newland, P., Riffelmann, M., Meade, B. D., Corbel, M., Gaines-Das, R. (2009). Characterization of Reference Materials for Human Antiserum to Pertussis Antigens by an International Collaborative Study. CVI 16: 303-311 [Abstract] [Full Text]  
  • Banus, S., Bottema, R. W. B., Siezen, C. L. E., Vandebriel, R. J., Reimerink, J., Mommers, M., Koppelman, G. H., Hoebee, B., Thijs, C., Postma, D. S., Kimman, T. G., Stelma, F. F. (2007). Toll-Like Receptor 4 Polymorphism Associated with the Response to Whole-Cell Pertussis Vaccination in Children from the KOALA Study. CVI 14: 1377-1380 [Abstract] [Full Text]  
  • Geurtsen, J., Banus, H. A., Gremmer, E. R., Ferguson, H., de la Fonteyne-Blankestijn, L. J. J., Vermeulen, J. P., Dormans, J. A. M. A., Tommassen, J., van der Ley, P., Mooi, F. R., Vandebriel, R. J. (2007). Lipopolysaccharide Analogs Improve Efficacy of Acellular Pertussis Vaccine and Reduce Type I Hypersensitivity in Mice. CVI 14: 821-829 [Abstract] [Full Text]  
  • Aase, A., Herstad, T. K., Merino, S., Brandsdal, K. T., Berdal, B. P., Aleksandersen, E. M., Aaberge, I. S. (2007). Opsonophagocytic Activity and Other Serological Indications of Bordetella pertussis Infection in Military Recruits in Norway. CVI 14: 855-862 [Abstract] [Full Text]  
  • Litt, D. J., Samuel, D., Duncan, J., Harnden, A., George, R. C., Harrison, T. G. (2006). Detection of anti-pertussis toxin IgG in oral fluids for use in diagnosis and surveillance of Bordetella pertussis infection in children and young adults.. J Med Microbiol 55: 1223-1228 [Abstract] [Full Text]  
  • Harnden, A., Grant, C., Harrison, T., Perera, R., Brueggemann, A. B, Mayon-White, R., Mant, D. (2006). Whooping cough in school age children with persistent cough: prospective cohort study in primary care. BMJ 333: 174-177 [Abstract] [Full Text]  
  • Baughman, A. L., Bisgard, K. M., Edwards, K. M., Guris, D., Decker, M. D., Holland, K., Meade, B. D., Lynn, F. (2004). Establishment of Diagnostic Cutoff Points for Levels of Serum Antibodies to Pertussis Toxin, Filamentous Hemagglutinin, and Fimbriae in Adolescents and Adults in the United States. CVI 11: 1045-1053 [Abstract] [Full Text]  
  • Templeton, K. E., Scheltinga, S. A., van der Zee, A., Diederen, B. M. W., Kruijssen, A. M., Goossens, H., Kuijper, E., Claas, E. C. J. (2003). Evaluation of Real-Time PCR for Detection of and Discrimination between Bordetella pertussis, Bordetella parapertussis, and Bordetella holmesii for Clinical Diagnosis. J. Clin. Microbiol. 41: 4121-4126 [Abstract] [Full Text]  
  • Crowcroft, N S, Booy, R, Harrison, T, Spicer, L, Britto, J, Mok, Q, Heath, P, Murdoch, I, Zambon, M, George, R, Miller, E (2003). Severe and unrecognised: pertussis in UK infants. Arch. Dis. Child. 88: 802-806 [Abstract] [Full Text]  
  • Kosters, K., Reischl, U., Schmetz, J., Riffelmann, M., Wirsing von Konig, C. H. (2002). Real-Time LightCycler PCR for Detection and Discrimination of Bordetella pertussis and Bordetella parapertussis. J. Clin. Microbiol. 40: 1719-1722 [Abstract] [Full Text]  
  • Salmaso, S., Mastrantonio, P., Tozzi, A. E., Stefanelli, P., Anemona, A., Atti, M. L. C. d., Giammanco, A., the Stage III Working Group, (2001). Sustained Efficacy During the First 6 Years of Life of 3-Component Acellular Pertussis Vaccines Administered in Infancy: The Italian Experience. Pediatrics 108: e81-81 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»